4//SEC Filing
Shah Preetam 4
Accession 0001601485-25-000065
CIK 0001601485other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 5:12 PM ET
Size
5.7 KB
Accession
0001601485-25-000065
Insider Transaction Report
Form 4
Shah Preetam
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2025-04-15+191,624→ 191,624 totalExercise: $4.98Exp: 2035-04-15→ Common Stock (191,624 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 25% of the options on March 24, 2025, the first anniversary of the Reporting Person's start date, with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Elicio Therapeutics, Inc.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001787403
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 5:12 PM ET
- Size
- 5.7 KB